
High WBC Predicts Relapse in Ph+ ALL Treated with Blinatumomab
Photo Credit: Nemes Laszlo The following is a summary of “Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab,” published in the May 2025 issue of Journal of Hematology & Oncology by …